Literature DB >> 12406304

Precancerous foci in pleomorphic adenoma of the salivary gland: recognition of focal carcinoma and atypical tumor cells by P53 immunohistochemistry.

Sachiko Ohtaké1, Jun Cheng, Hiroko Ida, Makoto Suzuki, Kazufumi Ohshiro, Weiguo Zhang, Takashi Saku.   

Abstract

BACKGROUND: It is still controversial if atypical tumor cells scattered in salivary pleomorphic adenomas are precancerous and how carcinoma arises in pleomorphic adenomas.
METHODS: We studied clinicopathologically the frequency and variation of cellular atypia among tumor cells and examined the expression status of p53 gene products as well as proliferating cell nuclear antigen (PCNA) in 101 surgical materials of pleomorphic adenomas.
RESULTS: Histopathologically, atypical tumor cells were found in 51% of the cases examined. Their mode of distribution was classified into three groups: focal (six cases, 6%) which could be identified as focal carcinoma, measuring less than 1 mm in diameter; sporadic (15 cases, 15%) and singular (30 cases, 30%). These atypical cells were located mainly within sheet-like nests of tumor cells but not in chondroid or fibro-hyaline foci. Immunohistochemically, most of the atypical cells were positive for p53 gene products and PCNA.
CONCLUSION: The results indicated that atypical cells with p53 protein accumulation in their nuclei could be regarded as cells in a precancerous state not yet forming an apparent carcinomatous nest. Some cell population with these atypical cells are likely to form focal carcinomas and then to an apparent form of carcinoma in pleomorphic adenoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12406304     DOI: 10.1034/j.1600-0714.2002.00040.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  7 in total

1.  XIAP and Ki-67: A Correlation Between Antiapoptotic and Proliferative Marker Expression in Benign and Malignant Tumours of Salivary Gland: An Immunohistochemical Study.

Authors:  Bhupesh Bhayyaji Bagulkar; Madhuri Gawande; Minal Chaudhary; Amol Ramchandra Gadbail; Swati Patil; Smita Bagulkar
Journal:  J Clin Diagn Res       Date:  2015-02-01

2.  Expression of Topoisomerase II-α protein in salivary gland tumors.

Authors:  Asaf Shvero; Ohad Hilly; Golan Bubis; Yaniv Hamzany; Rumelia Koren; Lea Rath-Wolfson
Journal:  Mol Clin Oncol       Date:  2017-10-20

3.  Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.

Authors:  Saori Matsubayashi; Toshio Yoshihara
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-20       Impact factor: 2.503

4.  Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence.

Authors:  T Hamada; S Matsukita; M Goto; S Kitajima; S K Batra; T Irimura; K Sueyoshi; K Sugihara; S Yonezawa
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

5.  The Stem Cell Marker Bmi-1 Is Sensitive in Identifying Early Lesions of Carcinoma ex Pleomorphic Adenoma.

Authors:  Bruno Tavares Sedassari; Maria Fernanda Setúbal Destro Rodrigues; Fernanda Viviane Mariano; Albina Altemani; Fábio Daumas Nunes; Suzana Sousa
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

6.  CD44 expression in pleomorphic adenoma, carcinoma ex pleomorphic adenoma and their adjacent normal salivary glands.

Authors:  Nafiseh Shamloo; Nasim Taghavi; Farzad Yazdani; Soudeh Shalpoush; Samane Ahmadi
Journal:  Dent Res J (Isfahan)       Date:  2018 Sep-Oct

7.  Establishment and characterization of pleomorphic adenoma cell systems: an in-vitro demonstration of carcinomas arising secondarily from adenomas in the salivary gland.

Authors:  Satoshi Maruyama; Jun Cheng; Susumu Shingaki; Takashi Tamura; Shuichi Asakawa; Shinsei Minoshima; Yoshiko Shimizu; Nobuyoshi Shimizu; Takashi Saku
Journal:  BMC Cancer       Date:  2009-07-21       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.